Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Gpr19 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of GPR19 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GPR19 mRNA | CTD | PMID:33387578 | 4,4'-diaminodiphenylmethane | decreases expression | ISO | Gpr19 (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in decreased expression of GPR19 mRNA | CTD | PMID:18648102 | 4,4'-sulfonyldiphenol | decreases methylation | ISO | GPR19 (Homo sapiens) | 6480464 | bisphenol S results in decreased methylation of GPR19 gene | CTD | PMID:31601247 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of GPR19 mRNA | CTD | PMID:30047161 | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of GPR19 mRNA | CTD | PMID:31881176 | all-trans-retinoic acid | decreases expression | ISO | GPR19 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of GPR19 mRNA | CTD | PMID:21934132 and PMID:33167477 | amitrole | decreases expression | EXP | | 6480464 | Amitrole results in decreased expression of GPR19 mRNA | CTD | PMID:30047161 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of GPR19 mRNA | CTD | PMID:16483693 | antirheumatic drug | decreases expression | ISO | GPR19 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of GPR19 mRNA | CTD | PMID:24449571 | benzo[a]pyrene | affects methylation | ISO | GPR19 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of GPR19 5' UTR and Benzo(a)pyrene affects the methylation of GPR19 intron | CTD | PMID:27901495 and PMID:30157460 | bis(2-ethylhexyl) phthalate | decreases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in decreased expression of GPR19 mRNA | CTD | PMID:15620428 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of GPR19 mRNA | CTD | PMID:25181051 | bisphenol A | decreases methylation | ISO | Gpr19 (Mus musculus) | 6480464 | bisphenol A results in decreased methylation of GPR19 promoter | CTD | PMID:27312807 | calcitriol | decreases expression | ISO | GPR19 (Homo sapiens) | 6480464 | Calcitriol results in decreased expression of GPR19 mRNA | CTD | PMID:21592394 | calcitriol | multiple interactions | ISO | GPR19 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of GPR19 mRNA | CTD | PMID:21592394 | cefaloridine | increases expression | EXP | | 6480464 | Cephaloridine results in increased expression of GPR19 mRNA | CTD | PMID:18500788 | CGP 52608 | multiple interactions | ISO | GPR19 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to GPR19 gene] | CTD | PMID:28238834 | chlorpyrifos | increases expression | ISO | Gpr19 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of GPR19 mRNA | CTD | PMID:37019170 | cyclosporin A | increases expression | ISO | GPR19 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of GPR19 mRNA | CTD | PMID:22147139 | cyclosporin A | increases methylation | ISO | GPR19 (Homo sapiens) | 6480464 | Cyclosporine results in increased methylation of GPR19 promoter | CTD | PMID:27989131 | cytarabine | increases expression | ISO | GPR19 (Homo sapiens) | 6480464 | Cytarabine results in increased expression of GPR19 mRNA | CTD | PMID:21198554 | D-mannitol | decreases expression | ISO | Gpr19 (Mus musculus) | 6480464 | Mannitol results in decreased expression of GPR19 mRNA | CTD | PMID:25270620 | dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of GPR19 mRNA | CTD | PMID:15620428 | disodium selenite | decreases expression | ISO | GPR19 (Homo sapiens) | 6480464 | Sodium Selenite results in decreased expression of GPR19 mRNA | CTD | PMID:18175754 | dorsomorphin | multiple interactions | ISO | GPR19 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of GPR19 mRNA | CTD | PMID:29391264 | epoxiconazole | decreases expression | ISO | Gpr19 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of GPR19 mRNA | CTD | PMID:35436446 | ethyl methanesulfonate | increases expression | ISO | GPR19 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in increased expression of GPR19 mRNA | CTD | PMID:23649840 | formaldehyde | increases expression | ISO | GPR19 (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of GPR19 mRNA | CTD | PMID:23649840 | FR900359 | affects phosphorylation | ISO | GPR19 (Homo sapiens) | 6480464 | FR900359 affects the phosphorylation of GPR19 protein | CTD | PMID:37730182 | furan | increases methylation | EXP | | 6480464 | furan results in increased methylation of GPR19 gene | CTD | PMID:22079235 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of GPR19 mRNA | CTD | PMID:33387578 | iron dichloride | decreases expression | ISO | GPR19 (Homo sapiens) | 6480464 | ferrous chloride results in decreased expression of GPR19 mRNA | CTD | PMID:35984750 | methamphetamine | increases expression | EXP | | 6480464 | Methamphetamine results in increased expression of GPR19 mRNA | CTD | PMID:19564919 | methimazole | decreases expression | EXP | | 6480464 | Methimazole results in decreased expression of GPR19 mRNA | CTD | PMID:30047161 | methyl methanesulfonate | increases expression | ISO | GPR19 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of GPR19 mRNA | CTD | PMID:23649840 | N-methyl-4-phenylpyridinium | increases expression | ISO | Gpr19 (Mus musculus) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of GPR19 mRNA | CTD | PMID:22776087 | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of GPR19 mRNA | CTD | PMID:20360939 | naphthalene | increases expression | ISO | Gpr19 (Mus musculus) | 6480464 | naphthalene results in increased expression of GPR19 mRNA | CTD | PMID:18978301 | nickel atom | increases expression | ISO | GPR19 (Homo sapiens) | 6480464 | Nickel results in increased expression of GPR19 mRNA | CTD | PMID:24768652 | Nonylphenol | decreases expression | EXP | | 6480464 | nonylphenol results in decreased expression of GPR19 mRNA | CTD | PMID:15620428 | oxaliplatin | decreases expression | EXP | | 6480464 | oxaliplatin results in decreased expression of GPR19 mRNA | CTD | PMID:25729387 | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of GPR19 mRNA | CTD | PMID:25729387 | paracetamol | affects expression | ISO | Gpr19 (Mus musculus) | 6480464 | Acetaminophen affects the expression of GPR19 mRNA | CTD | PMID:17562736 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of GPR19 mRNA | CTD | PMID:33387578 | phenethyl caffeate | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of GPR19 mRNA | CTD | PMID:20360939 | phenylmercury acetate | decreases expression | ISO | GPR19 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of GPR19 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | GPR19 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GPR19 mRNA | CTD | PMID:27188386 | potassium dichromate | increases expression | ISO | Gpr19 (Mus musculus) | 6480464 | Potassium Dichromate results in increased expression of GPR19 mRNA | CTD | PMID:23608068 | quercitrin | increases expression | ISO | GPR19 (Homo sapiens) | 6480464 | quercitrin results in increased expression of GPR19 mRNA | CTD | PMID:25193878 | SB 431542 | multiple interactions | ISO | GPR19 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Soman | increases expression | EXP | | 6480464 | Soman results in increased expression of GPR19 mRNA | CTD | PMID:19281266 | sulfadimethoxine | decreases expression | EXP | | 6480464 | Sulfadimethoxine results in decreased expression of GPR19 mRNA | CTD | PMID:30047161 | testosterone | decreases expression | ISO | GPR19 (Homo sapiens) | 6480464 | Testosterone results in decreased expression of GPR19 mRNA | CTD | PMID:21592394 | testosterone | multiple interactions | ISO | GPR19 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of GPR19 mRNA | CTD | PMID:21592394 | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of GPR19 mRNA | CTD | PMID:25729387 | topotecan | decreases expression | EXP | | 6480464 | Topotecan results in decreased expression of GPR19 mRNA | CTD | PMID:25729387 | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of GPR19 mRNA | CTD | PMID:33387578 | trichostatin A | increases expression | ISO | GPR19 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of GPR19 mRNA | CTD | PMID:26705709 | trichostatin A | multiple interactions | ISO | GPR19 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GPR19 mRNA | CTD | PMID:27188386 | trichostatin A | decreases expression | ISO | GPR19 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of GPR19 mRNA | CTD | PMID:24935251 and PMID:26272509 | triphenyl phosphate | increases expression | EXP | | 6480464 | triphenyl phosphate results in increased expression of GPR19 mRNA | CTD | PMID:30589522 | triptonide | increases expression | ISO | Gpr19 (Mus musculus) | 6480464 | triptonide results in increased expression of GPR19 mRNA | CTD | PMID:33045310 | trovafloxacin | decreases expression | ISO | Gpr19 (Mus musculus) | 6480464 | trovafloxacin results in decreased expression of GPR19 mRNA | CTD | PMID:35537566 | valproic acid | increases methylation | ISO | GPR19 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of GPR19 gene | CTD | PMID:29154799 | valproic acid | affects expression | ISO | GPR19 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of GPR19 mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | ISO | GPR19 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of GPR19 mRNA | CTD | PMID:24383497 | valproic acid | decreases expression | ISO | Gpr19 (Mus musculus) | 6480464 | Valproic Acid results in decreased expression of GPR19 mRNA | CTD | PMID:21427059 | vorinostat | increases expression | ISO | GPR19 (Homo sapiens) | 6480464 | vorinostat results in increased expression of GPR19 mRNA | CTD | PMID:27188386 | zinc atom | increases expression | EXP | | 6480464 | Zinc deficiency results in increased expression of GPR19 mRNA | CTD | PMID:12672911 | zinc(0) | increases expression | EXP | | 6480464 | Zinc deficiency results in increased expression of GPR19 mRNA | CTD | PMID:12672911 | |